IRON ADMINISTRATION DURING ERYTHROPOIETIN THERAPY IN HEMODIALYSIS-PATIENTS

被引:1
|
作者
FOURTOUNAS, C [1 ]
KAVADIAS, D [1 ]
TSOUCHNIKAS, J [1 ]
BARBOUTIS, K [1 ]
机构
[1] SERRES RENAL UNIT,SERRES,GREECE
来源
关键词
D O I
10.1177/039139889401701209
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
引用
收藏
页码:670 / 670
页数:1
相关论文
共 50 条
  • [21] OPTIMIZATION OF IRON THERAPY IN HEMODIALYSIS-PATIENTS TREATED WITH RHUEPO
    STIVELMAN, JC
    SEMINARS IN DIALYSIS, 1994, 7 (04) : 288 - 292
  • [22] SUBCUTANEOUS VERSUS INTRAVENOUS RECOMBINANT-HUMAN-ERYTHROPOIETIN ADMINISTRATION IN HEMODIALYSIS-PATIENTS
    BORAN, M
    DALVA, I
    YAZICIOGLU, A
    CETIN, S
    NEPHRON, 1993, 63 (01) : 113 - 114
  • [23] EFFECT OF VITAMIN-E ADMINISTRATION ON ERYTHROPOIETIN VALUES AND ANEMIA IN HEMODIALYSIS-PATIENTS
    AGUILERA, A
    TERUEL, JL
    VILLATRUELA, JJ
    RIVERA, M
    ORTUNO, J
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1993, 8 (04) : 379 - 379
  • [24] IMPORTANCE OF THE ADMINISTRATION ROUTE OF ERYTHROPOIETIN IN BLOOD-PRESSURE CONTROL IN HEMODIALYSIS-PATIENTS
    TERUEL, J
    NAVARRO, J
    PASCUAL, J
    GAMEZ, C
    LIANO, F
    MARCEN, R
    ORTUNO, J
    KIDNEY INTERNATIONAL, 1993, 44 (06) : 1480 - 1480
  • [25] ERYTHROPOIESIS AND ERYTHROCYTE AGE DISTRIBUTION IN HEMODIALYSIS-PATIENTS UNDERGOING ERYTHROPOIETIN THERAPY
    HAMPL, H
    RIEDEL, E
    SCIGALLA, P
    STABELL, U
    WENDEL, G
    BLOOD PURIFICATION, 1990, 8 (03) : 117 - 125
  • [26] IMPROVEMENT OF ERYTHROPOIETIN-INDUCED HYPERTENSION IN HEMODIALYSIS-PATIENTS CHANGING THE ADMINISTRATION ROUTE
    NAVARRO, JF
    TERUEL, JL
    MARCEN, R
    ORTUNO, J
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 1995, 29 (01): : 11 - 14
  • [27] TREATMENT OF ANEMIA RESISTANT TO CONVENTIONAL ERYTHROPOIETIN THERAPY WITH THYMOPENTIN IN HEMODIALYSIS-PATIENTS
    RAIOLA, P
    MANZO, M
    SAGGESE, A
    TOMASINO, G
    CICCHELLA, T
    RAMBALDI, M
    PISANO, M
    LIZZA, B
    PERNA, AF
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1995, 10 : 48 - 50
  • [28] VANCOMYCIN ADMINISTRATION TO HEMODIALYSIS-PATIENTS
    KELLER, F
    CLINICAL NEPHROLOGY, 1988, 30 (03) : 173 - 173
  • [29] BIOAVAILABILITY OF IRON IN HEMODIALYSIS-PATIENTS TREATED WITH ERYTHROPOIETIN - EVIDENCE FOR THE INHIBITORY ROLE OF ALUMINUM
    DONNELLY, SM
    ALI, MAM
    CHURCHILL, DN
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1990, 16 (05) : 447 - 451
  • [30] CORRECTION OF DEFICIENT PHAGOCYTOSIS DURING ERYTHROPOIETIN TREATMENT IN MAINTENANCE HEMODIALYSIS-PATIENTS
    VEYS, N
    VANHOLDER, R
    RINGOIR, S
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1992, 19 (04) : 358 - 363